Example: Heart Attack

Clinical Trials on Lymphoma, T-Cell, Peripheral

Total 310 results

NCT04569032

Not yet recruiting

A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression

Conditions: Peripheral T-cell Lymphoma
NCT04548700

Not yet recruiting

Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL

Conditions: Treatment-naïve; Peripheral T Cell Lymphoma
NCT04526834

Not yet recruiting

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

Conditions: Anaplastic Large Cell Lymphoma; Peripheral T Cell Lymphoma; Extranodal NK/T-cell Lymphoma; Diffuse Large B Cell Lymphoma; Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
NCT04512534

Not yet recruiting

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

Conditions: Peripheral T-cell Lymphoma
NCT04489264

Not yet recruiting

The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

Conditions: Peripheral T Cell Lymphoma
NCT04480099

Recruiting

Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Conditions: Peripheral T-cell Lymphoma
NCT04480125

Recruiting

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

Conditions: Peripheral T-cell Lymphoma
NCT04480788

Not yet recruiting

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

Conditions: T Lymphoblastic Leukemia/Lymphoma; Extramedullary NK-T-cell Lymphoma, Nasal Type; Peripheral T-cell Lymphoma, Nonspecific; Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Anaplastic Large Cell Lymphoma, ALK-negative; T-cell Lymphoblastic Leukemia
NCT04470141

Not yet recruiting

A Study of SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma

Conditions: Peripheral T Cell Lymphoma
NCT04457830

Not yet recruiting

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

Conditions: Peripheral T Cell Lymphoma
NCT04447027

Not yet recruiting

A Phase 1 Study of Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Conditions: Relapsed/Refractory T-cell Malignancies; Cutaneous T-Cell Lymphoma; Mature T-cell Malignancies; Peripheral T-Cell Lymphoma
NCT04444141

Recruiting

A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma

Conditions: Peripheral T-cell Lymphoma
NCT04425070

Not yet recruiting

A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma

Conditions: Peripheral T-cell Lymphoma; NK/T-cell Lymphoma
NCT04423926

Recruiting

Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

Conditions: PTCL, NOS; AITL; ALK- ALCL; Phase III-IV ALK+ ALCL; EATL
NCT04362007

Recruiting

A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma

Conditions: Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
NCT04334174

Recruiting

Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas

Conditions: T Cell Lymphoma
NCT04329130

Recruiting

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Conditions: Relapsed or Refractory Peripheral T-cell Lymphoma
NCT04312841

Not yet recruiting

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Conditions: B-Cell Prolymphocytic Leukemia; Chronic Lymphocytic Leukemia; Peripheral T-Cell Lymphoma; Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Sezary Syndrome; T-Cell Prolymphocytic Leukemia
NCT04254107

Recruiting

A Safety Study of SGN-TGT (SEA-TGT) in Patients With Advanced Cancer

Conditions: Non-small Cell Lung Cancer; Gastric Carcinoma; Classical Hodgkin Lymphoma; Diffuse Large B-cell Lymphoma; Peripheral T-cell Lymphoma
NCT04251065

Not yet recruiting

A Multicenter Clinical Trial of Daratumumab in Combination With Gemcitabine, Dexamethasone and Cisplatin in Patients With Relapsed/Refractory CD38 Positive PTCL-NOS, Angioimmunoblastic T-cell Lymphoma AITL and Other Nodal Lymphomas of T Follicular Helper Cells Origin

Conditions: Refractory T-Cell Lymphoma; Relapsed T-Cell Lymphoma
NCT04234048

Not yet recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Conditions: T-cell Lymphoma; Cutaneous/Peripheral T-Cell Lymphoma; Peripheral T-cell Lymphoma; Peripheral T-Cell Lymphoma, Not Classified; Primary Cutaneous T-cell Lymphoma; Cutaneous T-Cell Lymphoma, Unspecified; Cutaneous T-cell Lymphoma; Follicular T-Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Sézary's Disease; Mycosis Fungoides
NCT04233697

Withdrawn

Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma

Conditions: Lymphoma, T-Cell
NCT04213209

Recruiting

Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

Conditions: Peripheral T Cell Lymphoma; Pediatric Hodgkin Lymphoma
NCT04108325

Not yet recruiting

A Phase Ib Study of YY-20394 in Patients With Recurrent or Refractory Peripheral T-Cell Lymphoma

Conditions: Recurrent or Refractory Peripheral T-Cell Lymphoma
NCT04105010

Recruiting

Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)

Conditions: Peripheral T Cell Lymphoma
NCT04101331

Recruiting

Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides

Conditions: Peripheral T Cell Lymphoma; Transformed Mycosis Fungoides
NCT04083495

Recruiting

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Conditions: Peripheral T Cell Lymphoma
NCT04074746

Recruiting

Bispecific Antibody AFM13 Combined With NK Cells for Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas

Conditions: Recurrent Anaplastic Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Classic Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Recurrent Peripheral T-Cell Lymphoma; Refractory Anaplastic Large Cell Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Classic Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Peripheral T-Cell Lymphoma; TNFRSF8 Positive
NCT04072458

Recruiting

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

Conditions: Mantle Cell Lymphoma; Peripheral T-cell Lymphoma (PTCL); Cutaneous T-cell Lymphoma (CTCL); Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL); Follicular Lymphoma; Marginal Zone Lymphoma; Hodgkin Lymphoma; Waldenstrom Macroglobulinemia; DLBCL
NCT04061772

Recruiting

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

Conditions: Peripheral T Cell Lymphoma
NCT04045470

Recruiting

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

Conditions: Cutaneous T Cell Lymphoma; Peripheral T Cell Lymphoma
NCT04040491

Recruiting

PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma

Conditions: Peripheral T-cell Lymphoma
NCT04028440

Recruiting

γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Conditions: Non-Hodgkin's Lymphoma; Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma; Chronic Lymphoblastic Leukemia; Peripheral T Cell Lymphoma
NCT04021082

Withdrawn

CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)

Conditions: Peripheral T-Cell Lymphoma (PTCL NOS); Nodal Lymphomas of T Follicular Helper (TFH); Follicular T-cell Lymphoma (FTCL); AITL; ALCL; HSTCL; EATL I,II; MEITL, EATL Type II; Nasal Lymphoma
NCT04018248

Recruiting

BR101801 in Adult Patients With Advanced Hematologic Malignancies( Phase I)

Conditions: Diffuse Large B Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia; B Cell Lymphoma; Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia; Peripheral T Cell Lymphoma
NCT04008394

Recruiting

Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies

Conditions: Adult T-Cell Lymphoma/Leukaemia; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; NK/T-cell Lymphoma; Peripheral T Cell Lymphoma; Hodgkin Lymphoma
NCT03999658

Not yet recruiting

A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

Conditions: Peripheral T Cell Lymphoma; Diffuse Large B Cell Lymphoma; Biliary Tract Cancer; Extranodal NK T Cell Lymphoma, Nasal
NCT03964480

Recruiting

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

Conditions: Peripheral T-Cell Lymphoma
NCT03952572

Recruiting

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Conditions: Peripheral T-cell Lymphoma
NCT03947255

Recruiting

A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma

Conditions: Hodgkin Lymphoma; Peripheral T Cell Lymphoma; Anaplastic Large Cell Lymphoma
NCT03927105

Active, not recruiting

Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Conditions: Peripheral T Cell Lymphoma
NCT03922724

Recruiting

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Conditions: Peripheral T-cell Lymphomas; Lymphoproliferative Disorders; Immune System Diseases
NCT03921879

Recruiting

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Conditions: Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, B-Cell; Lymphoma, T-Cell; Lymphoma, Follicular; Lymphoma, Peripheral T-Cell; Lymphoma, Hodgkin
NCT03905135

Recruiting

Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies

Conditions: Peripheral T-cell Lymphoma NOS; Mycosis Fungoides; Sezary Syndrome; Anaplastic Large Cell Lymphoma
NCT03902184

Recruiting

IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

Conditions: Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Mycosis Fungoides/Sezary Syndrome
NCT03884205

Recruiting

GDPE/CEOPE Compared With CEOPE for Newly Diagnosed Patients With PTCL

Conditions: PTCL; Gemcitabine
NCT03776279

Recruiting

A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma

Conditions: Relapsed or Refractory Peripheral T-cell and NK/T-cell Lymphoma
NCT03742921

Recruiting

ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

Conditions: Lymphoma, T-Cell, Peripheral
NCT03719105

Recruiting

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Conditions: NK-Cell Lymphoma; NK-Cell Leukemia; Peripheral T Cell Lymphoma
NCT03672084

Recruiting

Allo-HSCT as First-line Consolidation in High-risk PTCL

Conditions: T Cell Lymphoma

COOKIE SETTINGS

Clinical Trials on Lymphoma, T-Cell, Peripheral